Sana Biotechnology share price logo

Sana Biotechnology

NASDAQ: SANA

Small Cap

$2.37

+0.03

(+1.28%)

as on

Sana Biotechnology Stock Performance

as on November 7, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.28
    $2.48
    downward going graph

    3.80%

    Downside

    4.64%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.22
    $5.49
    downward going graph

    6.33%

    Downside

    131.65%

    Upside

    downward going graph

Sana Biotechnology share price movements today

Previous Close
$2.34
Open
$2.48
Volume
1.7M
Market Cap
$700.5M
Day's Low - High
$2.28 - $2.48
52 Week Low - High
$2.22 - $5.49

Sana Biotechnology Historical Returns

1 Month Return
-12.87 %
3 Month Return
-32.67 %
1 Year Return
-42.05 %
3 Year Return
-38.92 %
5 Year Return
-89.58 %

Sana Biotechnology Stock Fundamentals & Key Indicators

Check Sana Biotechnology market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$700.5M

EPS (TTM)

-0.53

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.47

Industry PE ratio

-7.71

PEG Ratio

-0.07

EBITDA

-143.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-97.08%

Sana Biotechnology vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sana Biotechnology with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$700.5M-89.58%-4.470.00%0.00%
Neutral$96.4B7.26%-35.9528.00%0.00%
StrongBuy$44.1BNA27.9287.82%0.00%
StrongBuy$137.5B183.69%34.9485.57%0.00%
Buy$96.3B47.88%19.2685.77%0.41%

Stock Returns calculator for Sana Biotechnology Stock including INR - Dollar returns

The Sana Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Sana Biotechnology investment value today

Current value as on today

₹61,345

Returns

-₹38,655

(-38.66%)

Returns from Sana Biotechnology Stock

-₹42,054 (-42.05%)

Dollar Impact

₹3,399 (+3.4%)

Analyst Recommendation on Sana Biotechnology Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Sana Biotechnology. Average target price of $8.43

Sana Biotechnology Share Price Target

Get share price movements and forecasts by analysts on Sana Biotechnology.

What analysts predicted

71.89%UPSIDE

Target Price

$8.43

Current Price

$2.37

Analyzed by

3 Analysts

High

$12

Target

$8.43

Low

$7

Sana Biotechnology target price $8.43, a slight upside of 71.89% compared to current price of $2.37. According to 3 analysts rating.

Indian Investors' Interest in Sana Biotechnology Stock

Search interest for Sana Biotechnology Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-43% versus previous 30 day period

Sana Biotechnology Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-2
-
-
Operating Income
-49
-61
-50
-50
-94
-43
-61
-37
-65
18
EBITDA
-46
-55
-43
-45
-47
-38
-55
-44
-61
18
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
3
4
5
3
2
3
3
2
2
-
Income Before Tax
-50
-59
-49
-49
-93
-42
-58
-47
-63
20
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-50
-59
-49
-49
-93
-42
-58
-47
-63
20
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Sana Biotechnology Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
-3
-10
-
-
-
-
-12
Operating Income
-8
-141
-161
-356
-272
-293
-272
-190
EBITDA
-13
-140
-291
-344
-253
-258
-251
-231
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
0
1
5
11
15
24
15
12
Income Before Tax
-13
-138
-297
-355
-269
-283
-266
-244
Income Tax Expense
-
-7
-11
-
-
-
-
-
Net Income
-13
-130
-285
-355
-269
-283
-266
-244
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Sana Biotechnology Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
-50
-59
-49
-49
-93
-42
-58
-47
-63
20
Operating Cash Flow
-58
-51
-47
-48
-33
-29
-32
-37
-32
-38
Investing Cash Flow
5
41
47
16
7
-48
-16
49
-87
22
Financing Cash Flow
10
2
0
0
0
109
17
0
93
-
Change in Cash
-42
-7
0
-31
-24
32
-31
11
-26
-16

Sana Biotechnology Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-13
-130
-285
-355
-269
-283
-266
-244
Operating Cash Flow
-13
-85
-137
-251
-290
-253
-223
-143
Investing Cash Flow
0
-87
-252
-245
210
172
17
-40
Financing Cash Flow
45
223
435
631
4
31
199
128
Change in Cash
31
50
45
134
-74
-49
-5
-55

Global Institutional Holdings in Sana Biotechnology

Check out the Institutions with significant holdings in Sana Biotechnology.

Funds
Holdings
Noubar Afeyan
8.35%
Robert Nelsen
7.60%
Peter Kolchinsky
6.26%
BlackRock, Inc.
5.57%
Fidelity Mt. Vernon Street Trust
5.50%

Sana Biotechnology News & Key Events

  • img

    Today's Timeline - 15 October

    Wed, 09:37 PM

    -

    Sana Biotechnology shares surged after Eric Jackson named it a potential 100-bagger, citing scientific achievements and macro trends.

Insights on Sana Biotechnology

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 256.3% return, outperforming this stock by 285.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 935.8% return, outperforming this stock by 977.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SANA stock has moved down by -7.8%

About Sana Biotechnology

Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range of conditions with significant unmet medical needs, including various cancers, diabetes, central nervous system disorders, cardiovascular diseases, and genetic illnesses. Its portfolio of drug candidates includes SG295 and SG242, which are designed to target CD19+ cancer cells involved in non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia. For multiple myeloma, Sana is progressing SG221, SG239, and SC255. Other pipeline assets include SG328 for ornithine transcarbamylase deficiency, and SG418 for sickle cell disease and beta-thalassemia. Additionally, the company is advancing SC291, a CD19 allogeneic T cell therapy, SC451 for type I diabetes mellitus, and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Founded in 2018 as FD Therapeutics, Inc., the company adopted its current name, Sana Biotechnology, Inc., in September 2018 and is based in Seattle, Washington.
OrganisationSana Biotechnology
Headquarters188 East Blaine Street, Seattle, WA, 98102, US
IndustryBiotechnology
CEOSteven D. Harr

Key Management of Sana Biotechnology

Name

Title

Dr. Steven D. Harr M.D.

President, CEO & Director

Mr. Brian D. Piper M.B.A.

Executive VP & CFO

Ms. Susan Wyrick

Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting

Mr. Aaron M. Grossman

Executive VP, Chief Legal Officer & Corporate Secretary

Ms. Debra Wisdom

VP & Head of People

Mr. Snehal Patel

Executive VP & Chief Technical Officer

Dr. Dhavalkumar D. Patel M.D., Ph.D.

Executive VP & Chief Scientific Officer

Dr. Gary Meininger M.D.

Executive VP & Chief Medical Officer

Dr. Yuko Soneoka J.D., Ph.D.

SVP & Head of Intellectual Property

Mr. John Gerecitano M.D., Ph.D.

Senior Vice President, Clinical Lead, Hematology & Oncology Development

FAQs

What is Sana Biotechnology share price today?

Sana Biotechnology share price today is $2.37 as on at the close of the market. Sana Biotechnology share today touched a day high of $2.48 and a low of $2.28.

What is the 52 week high and 52 week low for Sana Biotechnology share?

Sana Biotechnology share touched a 52 week high of $5.49 on and a 52 week low of $2.22 on . Sana Biotechnology stock price today i.e. is closed at $2.37,which is 56.83% down from its 52 week high and 6.76% up from its 52 week low.

What is Sana Biotechnology's market capitalisation today?

Sana Biotechnology market capitalisation is $0.00T as on .

How to invest in Sana Biotechnology Stock (SANA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sana Biotechnology on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Sana Biotechnology Stock (SANA) from India?

Indian investors can start investing in Sana Biotechnology (SANA) shares with as little as ₹93.91000366210938 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.10 in Sana Biotechnology stock (as per the Rupee-Dollar exchange rate as on ). Based on Sana Biotechnology share’s latest price of $2.37 as on November 7, 2026 at 8:46 am IST, you will get 4.2194 shares of Sana Biotechnology. Learn more about fractional shares .

What are the returns that Sana Biotechnology has given to Indian investors in the last 5 years?

Sana Biotechnology stock has given -89.58% share price returns and 27.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?